News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Arno Therapeutics Adds Steven Rubin, EVP of Opko Health, Inc., as Board Observer


11/18/2013 8:59:57 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

FLEMINGTON, N.J., Nov. 18, 2013 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of targeted oncology therapeutics, today announced that Steven D. Rubin, Executive Vice President, Administration and Director of OPKO Health, Inc. (NYSE:OPK) has been designated by OPKO Health as a non-voting observer to Arno's Board of Directors, effective immediately.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES